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Purpose: This study introduces an advanced method to 
evaluate and extent the adjustment of the prescribed dose to 
maintain the same clinical results, when changing the dose 
calculation algorithm type (a), i.e density correction method 
to more recently type (b) algorithm, i.e AAA.  
Material and methods: 10 cases with lung cancer were 
studied. For each case, 3 treatment plans were generated. 
Plan 1 was generated using type (a) algorithm, and Plan 2 
using type (b) algorithm. In plan 3 the dose was calculated 
with type (b) algorithm using monitor units from plan 1 as 
input. A global analysis based on 2D and 3D gamma (γ) was 
made to evaluate the under / overestimation of calculated 
dose. Clinical evaluation was carried out using Tumour 
Control Probability (TCP) and Normal Tissue Complication 
Probabilities (NTCP) based on Uniform Equivalent Dose 
model. Assuming a constant TCP, the ratio “R= TCP/NTCP” 
and Uncomplicated Tumor Control Probability (UTCP) were 
calculated to measure the clinical benefit – toxicity. 
Wilcoxon test was used to evaluate the significance of the 
differences and the correlation coefficient (r) was calculated 
using Spearman’s rank test. 
Results: The dose calculated with algorithm type (b) was 
significantly overestimated to organs at risks while the 
delivered dose in MU was underestimated, p < 0.001. 
Therefore, γ maps confirmed the dosimetric results. 
Moreover, there were a significant difference for NTCP for 
lung and heart. The ratio “R” from plan 1 and plan 2 were 
significantly different, indicating that to maintain the same 
effect benefit and toxicity the prescribed dose should be 
readjusted. 
Conclusion: We assessed the prescribed dose using the 
radiobiological models. The ratio of benefit was significantly 
changed when moving from type (a) algorithm to type (b) 
algorithm. This indicate that the prescribed dose should be 
readjusted when type (b) algorithm will be integrated in 
radiation oncology. A discussion between oncologist and 
physicist is quite necessary in order to readjust the 
prescribed dose. 
 
Key words: TCP, NTCP, EUD, gamma maps. 
 
48 
62 MeV Proton beams induced DNA damage in hypoxic 
conditions. 
P. Chaudhary1, T. Marshall1, L. Manti4, F. J. Currell3, F. 
Romano5, P. G. Cirrone5, G. Schettino1,2, K. M. Prise1 
1 Centre for Cancer Research and Cell Biology, Queen’s 
University Belfast, UK 
2 National Physical Laboratory, Hampton Road, Teddington, 
Middlesex, England, UK 
3 School of Mathematics and Physics, Queen’s University 
Belfast, UK 
4 Department of Physics, University of Naples Federico II, 
Italy. 
5 Istituto Nazionale di Fisica Nucleare, LNS, Catania, Italy 
 
Purpose: Hypoxia represents one of the most important 
challenges of current radiotherapy that can potentially affect 
the treatment planning and outcome. For the optimization of 
proton therapy and its application in treating hypoxic tumors 
such as dose and LET painting it is important to study the 
DNA damage response of normal cells under hypoxic and 
radio resistant conditions. The present study is aimed at 
understanding the variations in DNA double strand breaks 
induction and repair along prisitine and Spread-Out-Bragg-
Peak Proton beams under hypoxic. 
Materials and methods: DNA DSB damage and repair response 
was studied in AG01522 cells irradiated at various positions 
along the 62 MeV therapeutic protons Bragg peak at the 
CATANA beam line of the Institute of Nuclear Physics (INFN) 
Catania, Italy. Hypoxia was mimicked by using Cobalt 
chloride (CoCl2) and Dimethyl Sulphoxide (DMSO) was used as 
a Reactive Oxygen Species (ROS) scavenger. Hypoxia 
induction was confirmed by immunofluorescent staining of 
Hypoxia inducible factor-1 alpha (HIF-1α) and DNA DSB 
induction was quantified using p53 Binding protein-1 (53BP1) 
foci.  
Results: The presence of DMSO and CoCl2 reduced the 53BP1 
foci by 40% as compared to foci induction under normoxic 
conditions (30 minutes) in the cells irradiated at the entrance 
position of pristine beam. Cells irradiated at the Bragg peak 
revealed a significant induction of residual DSB damage even 
in presence of DMSO and CoCl2 at 24 hrs. Cells irradiated at 
distal end positions of the SOBP also revealed a significant 
induction of the 53BP1 foci irrespective of the oxygenation 
conditions of the medium. 
Conclusions: Our results indicate the variations in the 
induction and repair of DNA DSBs in presence of ROS 
scavenger and Hypoxia along the Bragg peak. These findings 
can be of potential application in the tumor treatment 
planning of hypoxic tumors especially near the critical organs 
and combining DNA repair inhibitors approach. 
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Purpose: Hypoxic tumors still pose a challenge for modern 
radiotherapy. Hadrontherapy has gained momentum world 
wide as an effective modality for tumor therapy including 
success in inducing cell death in cancer cells under hypoxia 
as reported by several investigators. Significant advances in 
laser technologies have led to the prospect of using laser-
accelerated ions, emitted in ultrashort bursts, as a future, 
cost-saving alternative to conventional accelerators. An 
understanding of the radiobiological effects at the ultrahigh 
dose rate delivered by these short ions pulses on human cells 
under hypoxic conditions is important for the development 
and further advancement of this technology towards clinical 
applications.  
Materials and methods: Laser accelerated 15-18 MeV protons 
generated using the Nd:glass VULCAN laser system at the 
Rutherford Appleton Laboratory, Oxford, UK, were delivered,  
by a compact magnetic transport system, to cell samples at 
dose rates exceeding 109 Gy/s. Dosimetry was validated using 
EBT2 gafchromic films and CR-39 tracks detector. Normal 
human skin fibroblasts (AG01522 cells) monolayers grown in 
custom made stainless steel, on 3 μm thin Mylar dishes were 
pre-gassed with hypoxic gas mixture (95% nitrogen and 5% 
Carbon-di-oxide) for 4 hours and irradiated inside portable 
beam-line hypoxia chambers. Hypoxia induction was 
confirmed using HIF-1 alpha immuostaining. DNA damage and 
repair kinetics was studied using 53BP1 foci formation assay 
up to 24 hours after irradiation under both normoxic and 
hypoxic conditions. 
Results: Our preliminary data suggests the effectiveness of 
Laser accelerated protons in DNA damage induction under 
both normoxic and hypoxic conditions. We observed a small 
reduction in average foci induction at initial time points in 
hypoxic cells, which was not seen after 2 hrs. 
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Conclusions: We report here for the first time measurements 
of DNA damage with pulsed protons at ultrahigh dose rate 
(109-1010 Gy/s) under hypoxic conditions.  
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We have used the calorimeter module originally designed for 
the SuperNEMO experiment to measure the energies of 
protons at the Clatterbridge proton therapy cyclotron. 
Such measurements are necessary for time consuming QA 
checks, and by improving the rates and energy resolution this 
time can be considerably reduced.  
Preliminary results show that an energy resolution of sigma 
0.7% can be achieved for low rates which will later be 
compared to the high rate data. We hope to extend this 
technique to proton radiography as well. 
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Introduction: Cancer treatment by radiotherapy is a complex 
process and needs accurate radiation treatment delivery and 
can be verified using in vivo measurements. Optically 
stimulated luminescence dosimeter [OSLD] has been used 
extensively for beam dosimetry, radiation protection 
including in vivo measurements due to their simple readout 
process and multiple times readout facility.  
Aim and Objective: The aim of the present work is to study 
the dosimetric characteristics of commercial OSL system by 
Landauer Inc. before using it for clinical practice in 
radiotherapy. 
Material and Methods: The OSLD system used is a commercial 
InLightTM microstar reader system, manufactured by Landauer 
Inc. The detector consist of Al2O3:C nanodot as OSL material, 
enveloped in special light protective plastic holders. In the 
present study the irradiations are carried out in 30*30 cm2 
solid water slab phantoms. Bhabhatron – II cobalt 60 
telecobalt radiation is used for most of the measurements 
carried out. Clinac – iX is also used for 6 MV and 10MV energy 
photon beams to study dose rate and energy dependence. 
Absolute dose is measured using a 30013 PTW ionization 
chamber in solid water and compared with OSL dosimeter 
measurements. 
Unless otherwise mentioned, all irradiations carried out using 
an SSD setup (80cm for co-60 and 100cm for linac) with 
10*10cm2 field size.OSL response with given dose is 
investigated for doses ranging from 0.5 to 4Gy. Energy 
dependence of OSL is investigated for Co-60, 6MV, 10MV 
beams, delivering a dose of 50 cGy each. Further the dose 
rate dependence of OSL detector is evaluated for dose rates 
of 200, 400, 600 cGy/min in accelerator with 6MV energy 
beam. We also studied the field size dependence by 
irradiating OSLD chips to 50 cGy dose for various field sizes 
ranging from 4*4 to 35*35 cm2 for cobalt -60 beam. The 
dosimeter angular response is studied at various gantry 
angles from 90º to 270º, at an interval of 30º, with and 
without build up respectively. 
Results: In present study it was observed that the OSL dose 
deviation is about - 4.5% as compared with ionization 
chamber. Further the reproducibility of detector is found to 
be within 3.44% standard deviation, with COV 0.035. There is 
no significant energy dependence of Al2O3:C detector for the 
energy range Co-60 to 10MV. The detector response was 
found to be linear in the dose range of 0.5 to 4Gy. The 
detector response is almost independent in clinical dose rate 
range, nearly independent of field size and is independent to 
angle of incidence of beam.  
Discussion: The dosimetric characteristics of OSL system were 
studied and found that OSL response is energy and dose rate 
independent. The stability of system and linear dose 
response relationship makes it a good dosimeter for in vivo 
dosimetry in clinical radiotherapy.  
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Background: Air filled ionization chambers are the dosimeters 
of choice for photon therapy as well as particle therapy. 
Dosimetry protocols for ion beams take recombination effects 
into account, where the generated charge in the ionization 
chamber may recombine before it is picked up by the 
electrode. It is well established that intra-track 
recombination (initial recombination) is negligible in medical 
photon and electron beams, but must be accounted for in 
beams with heavy ions. However, the underlying assumptions 
for establishing the recommended method for correction for 
inter-track recombination (general recombination) still 
remains unclear today [1]. The current two-voltage method 
only is applicable for low LET-beams, with no initial 
recombination present [2,3], and this progress report focuses 
on a detailed recombination study of ion beams. 
Here, we calculate the columnar recombination when the ion 
track is 
• parallel to the electric field 
• rotated with an angle between 0 and 𝜋𝜋/2 relative 
to the external field which was estimated 
analytically by Jaffé [4] and later confirmed 
experimentally by Kanai et al [5].  
The general recombination is investigated by 
• sampling two parallel ion tracks at different 
separation and initialized at different times 
• comparing the simulation of a continuous beam 
with Greening’s formula [6] for collection 
efficiency.  
Simulations are confirmed by comparison with experimental 
data.  
Methods: We have investigated positive and negative charge 
carrier distributions (CCDs) by solving the differential 
equation using a finite difference approach, 
 
with  derived from the initial CCDs,  the diffusion 
constant,  the mobility, for positive and negative CCDs, 
E  the electric field vector, and the recombination 
constant. 
Results: Our simulations reproduced the analytical solution 
from Jaffé and the experimental results by Kanai et al. On 
this platform we could also verify the Greening analytical 
solution.  
Conclusion: The simulations of pulsed and continuous beams 
are seen to agree well with the known theories and 
experimental data, and the program is thus capable of 
reproducing the initial and general recombination processes 
taking place in high LET-beams. This allows a deeper study of 
the actual recombination processes taking place when 
several ion tracks are present and ultimately account for the 
overall recombination in air filled ionization chambers 
irradiated with high LET-beams. 
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